» Articles » PMID: 34768694

Ocular Manifestations of Behçet's Disease: An Update on Diagnostic Challenges and Disease Management

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Nov 13
PMID 34768694
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Behçet's disease is a systemic vasculitis that affects multiple organs. The most common manifestations are oral and genital ulcerations and recurrent uveitis. Uveitis can be an initial symptom in 10-20% of cases and leads to blindness in 16-25% of patients. The management of this disease is evolving due to the clinical phenotypes recently described in the literature and increasing focus on the detection of subclinical inflammation to enable correct therapeutic decisions. The first line treatment is azathioprine, followed by various immunosuppressive and biological agents as alternatives in severe or refractory cases. This review summarizes scientific articles about the etiology of, diagnostic tools for and treatment of the ocular manifestations of Behçet's disease available in the PubMed database from 1 January 2016 to 1 May 2021. A multidisciplinary approach is necessary to effectively prevent permanent damage and thus improve the life quality of the patients. Therefore, it is crucial to raise awareness of the common clusters of symptoms, use of modern imaging methods, such as ocular computed tomography and fluorescein angiography, and novelty treatment algorithms to enable early diagnosis and appropriate management.

Citing Articles

Behçet's Syndrome Overall Damage Index performance and validation in an adult Egyptian cohort.

Attia D, Maged L Arch Rheumatol. 2025; 39(4):607-616.

PMID: 40060123 PMC: 11883263. DOI: 10.46497/ArchRheumatol.2024.10893.


Behcet's disease in a tertiary eye hospital in Pakistan.

Shalwani T, Khowaja A, Punjwani N Ther Adv Rare Dis. 2025; 6():26330040251314126.

PMID: 39830993 PMC: 11742144. DOI: 10.1177/26330040251314126.


TraceEyeDisease: a web-based database for investigating trace elements and their imbalances in eye diseases.

Choudhari J, Yadav H, Chouhan U BMC Res Notes. 2024; 17(1):334.

PMID: 39533428 PMC: 11556128. DOI: 10.1186/s13104-024-06981-8.


The Current and Novel Imaging Modalities for Ocular Vasculitis in Behcet's Disease: A Review.

Kaur M, Yip K Cureus. 2024; 16(9):e69528.

PMID: 39416569 PMC: 11482291. DOI: 10.7759/cureus.69528.


Novel genetic variants of HLA gene associated with Thai Behcet's disease (BD) patients using next generation sequencing technology.

Sornsamdang G, Shobana J, Chanprapaph K, Chantratita W, Chotewutmontri S, Limtong P Sci Rep. 2024; 14(1):7967.

PMID: 38575661 PMC: 10995258. DOI: 10.1038/s41598-024-58254-w.


References
1.
Zou J, Luo J, Shen Y, Cai J, Guan J . Cluster analysis of phenotypes of patients with Behçet's syndrome: a large cohort study from a referral center in China. Arthritis Res Ther. 2021; 23(1):45. PMC: 7847001. DOI: 10.1186/s13075-021-02429-7. View

2.
Margo C, Hamed L . Ocular syphilis. Surv Ophthalmol. 1992; 37(3):203-20. DOI: 10.1016/0039-6257(92)90138-j. View

3.
Papoutsis N, Abdel-Naser M, Altenburg A, Orawa H, Kotter I, Krause L . Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol. 2006; 24(5 Suppl 42):S125. View

4.
Gurlu V, Guclu H, Ozal A . Thickness changes in foveal, macular, and ganglion cell complex regions associated with Behçet uveitis during remission. Eur J Ophthalmol. 2015; 26(4):347-50. DOI: 10.5301/ejo.5000728. View

5.
Tugal-Tutkun I, Gupta V, Cunningham E . Differential diagnosis of behçet uveitis. Ocul Immunol Inflamm. 2013; 21(5):337-50. DOI: 10.3109/09273948.2013.795228. View